Product Designer (iOS, Web-to-App / W2A) at Clairo

Kyiv, Kyiv city, Ukraine

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Technology, Consumer Apps, Mobile AppsIndustries

Requirements

3–5+ years in Product/UI/UX Design for mobile apps, with solid experience in iOS
Portfolio that shows impact on conversion funnels, onboarding, paywall/checkout, and A/B tests
Thinks in metrics — CTR, CVR, install-to-trial, trial-to-paid, ARPU/LTV, churn
Confident use of AI tools throughout the design process
Advanced Figma user (components, variants, auto-layout, prototyping); AI plugins are a plus
Strong grasp of iOS HIG, in-app purchase/subscription patterns, and App Store Review Guidelines
Hands-on experience with A/B testing and experiment design
Understanding of AARRR / HEART frameworks, JTBD, CJM, and CRO principles for mobile
Ability to write detailed, clear specs — states, edge cases, localizations, text lengths
Moves fast and iterates even faster — exploring alternatives, explaining trade-offs, and maintaining top quality
Transparent in communication and thrives in short feedback loops with the Growth Manager
Nice to Have: Experience with localization, multi-currency flows, and pricing experiments
Nice to Have: Familiarity with win-back/renewal funnels, post-trial retention, and push/in-app messaging strategies

Responsibilities

Design and optimize the Web-to-App journey: FB Ad → W2A → Checkout → App Store → Onboarding
Iterate on W2A funnels and checkout flows: test messaging, step order, barriers, pricing, plans, and trial structures
Generate, score, and prioritize hypotheses using ICE/PIE frameworks
Deliver quick, testable solutions in Figma — with multiple versions ready for experimentation
Design and evolve onboarding, paywall, and purchase experiences; test messaging, pricing, trials, bundles, and localizations
Define analytics events, track key states, and validate implementation post-release
Build a lightweight design system for growth experiments — fast, flexible, and easy to iterate on
Collaborate closely with the Growth Manager and iOS team; bring data, AI, and user empathy together in every decision

Skills

Product Design

UI Design

UX Design

iOS

Figma

A/B Testing

Prototyping

Web-to-App

Checkout Optimization

Paywall Design

Onboarding

ICE Framework

PIE Framework

Design System

Analytics

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free